Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Tiny, magnetic spheres may help overcome gene therapy hurdle


The average person’s heart pumps about a gallon of blood per minute, a rate that can easily triple or quadruple during exercise.

The rapid flow of blood through the body is a major roadblock to the use of gene therapy to cure diseases. When injected into the blood, vector viruses – which carry corrective genes – tend to shoot past the target organ or tissue rather than sticking to it, like grains of sand moving past stones in a fast-flowing river.

Now, University of Florida gene therapy and biomedical engineering researchers have demonstrated a novel approach to the problem. In a July article in Molecular Therapy, they report attaching the adeno-associated virus, a widely used gene carrier, to the surface of tiny manufactured balls known as microspheres, each containing a miniscule particle of iron oxide. Using a magnet placed under culture dishes, the researchers were able to coax large amounts of the microspheres to target areas of the cultures. In related experiments in mice, the researchers showed the microspheres clung to cells or organs longer than the virus alone did.

The procedure, reminiscent of the toy that moves magnetized objects beneath transparent plastic, could someday evolve into a treatment that would enable doctors to guide corrective gene-containing microspheres injected into a patient with magnets placed outside the skin. Such procedures, could, for example, replace invasive catheterizations used to treat lung and heart diseases, the researchers said.

"By packaging the virus with the microsphere, we both guided it to the targeted area and got it to stick there," said Barry Byrne, the lead researcher and a pediatric cardiologist with the UF College of Medicine who is affiliated with the UF Genetics Institute.

Byrne and Cathryn Mah, an assistant research professor in the department of pediatrics, collaborated on the project with UF colleagues in pharmaceutics, genetics, and materials science and engineering. The effort, partially funded by the Whitaker Foundation, is part of UF’s growing biomedical engineering initiative involving a wide range of medical and engineering researchers.

Byrne said the adeno-associated virus, a virus that is an ideal gene carrier because it is not associated with any disease, is expensive and time consuming to manufacture in quantity. As a result, if it is ever to be widely used in treating disease, clinicians must have the ability to bind it specifically to the organ, tissue or cells they hope to treat, instead of having it dispersed through the body thus diminishing its effect.

"There is no way you could provide a systemic therapy spread throughout the body if you were only after the kidney, for example," said Byrne, of UF’s Powell Gene Therapy Center. "That even applies to dosing a mouse. Gene therapies are actually unachievable without some type of targeting."

It also is important to avoid unintentional release of therapeutic genes into reproductive cells in part so that engineered genes are not passed on to children, effectively altering the human genome, Byrne said. Proof that therapeutic genes do not spread beyond their targets – such dispersion could cause tumors in non-targeted cells – is one of the Food and Drug Administration’s main criteria for approving gene therapies, he said.

Mah said the UF team’s experiments were conducted over a period of about two years, much of that time devoted to the experiments in mice. In one experiment, the team injected the virus-coated microspheres into the tail veins of three mice and the free virus into the tail veins of three others. They monitored what happened by tracking "marker" proteins produced by the virus. The procedure was similar with cell cultures containing either the free virus or the virus-coated microspheres, with the researchers tracking the marker proteins through a technique called fluorescence microscopy, in which the proteins appear fluorescent green.

The results were impressive. The mice tail vein experiments revealed 10 times the expression of the marker protein in the target organ – the lung – than in other organs, indicating the microspheres both could be targeted and made to reside longer in their target than the free virus. In the cell cultures, meanwhile, the researchers achieved more than 100 times the expression of the marker protein in the magnetized areas of the culture versus the others.

"If you think about it in terms of making doses, it might take about six months to make a single-patient dose of this vector currently," Byrne said. "If this works, I’d say we could do it in four to six weeks or even less."

The microspheres used in the experiment were polystyrene, a type of plastic. In order for the spheres to be used in actual treatment, they would have to be made of biodegradable materials, said Chris Batich, a UF professor of materials science and engineering and biomedical engineering and member of the team. Although he said he has created such biodegradable microspheres since the project was first launched, they have yet to be tested. Among other challenges, researchers will have to prove the microspheres are harmless, efficient and predictable before they can be considered for use in clinical treatment, he said.

"You have to make sure they have the right properties," he said. "They have to have enough iron oxide to be pulled by the magnetic field, and you have to make sure they have the right rate of degradation, whether its two hours or two weeks."

Writer: Aaron Hoover,
Sources: Barry Byrne, (352) 846-1531,
Chris Batich, (352) 392-6630,

Barry Byrne | EurekAlert!
Further information:

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Space observation with radar to secure Germany's space infrastructure

Satellites in near-Earth orbit are at risk due to the steady increase in space debris. But their mission in the areas of telecommunications, navigation or weather forecasts is essential for society. Fraunhofer FHR therefore develops radar-based systems which allow the detection, tracking and cataloging of even the smallest particles of debris. Satellite operators who have access to our data are in a better position to plan evasive maneuvers and prevent destructive collisions. From April, 25-29 2018, Fraunhofer FHR and its partners will exhibit the complementary radar systems TIRA and GESTRA as well as the latest radar techniques for space observation across three stands at the ILA Berlin.

The "traffic situation" in space is very tense: the Earth is currently being orbited not only by countless satellites but also by a large volume of space...

Im Focus: Researchers Discover New Anti-Cancer Protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.

The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

New solar solutions for sustainable buildings and cities

23.03.2018 | Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

Latest News

For graphite pellets, just add elbow grease

23.03.2018 | Materials Sciences

Unique communication strategy discovered in stem cell pathway controlling plant growth

23.03.2018 | Agricultural and Forestry Science

Sharpening the X-ray view of the nanocosm

23.03.2018 | Physics and Astronomy

Science & Research
Overview of more VideoLinks >>>